Possible role of adjuvant therapy for thin malignant melanoma

G. L. Lewis, S. K. Tyring, R. F. Wagner

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

Patients with thin (less than 0.75 mm) malignant melanoma generally have an excellent prognosis following adequate surgical resection. However, some patients will experience recurrent disease. Once features for a high risk of recurrence in patients with malignant melanoma can be reliably identified, adjuvant intervention will be offered. Two formidable challenges remain before this strategy is adopted: we cannot yet accurately predict the subgroup of patients with thin malignant melanoma who will experience disease progression and an effective, nontoxic adjuvant regimen for this subgroup is not currently available. Future prospects for the adjuvant management of thin malignant melanoma are reviewed.

Original languageEnglish (US)
Pages (from-to)377-379
Number of pages3
JournalCutis
Volume50
Issue number5
StatePublished - Jan 1 1992

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Possible role of adjuvant therapy for thin malignant melanoma'. Together they form a unique fingerprint.

  • Cite this

    Lewis, G. L., Tyring, S. K., & Wagner, R. F. (1992). Possible role of adjuvant therapy for thin malignant melanoma. Cutis, 50(5), 377-379.